Cetrolix 0.25mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Cetrorelix (0.25mg)
Overview Cetrolix 0.25mg Injection
Infertility treatment in women utilizes Cetrolix 0.25mg Injection, a gonadotropin-releasing hormone antagonist. This medication prevents premature egg release, thereby aiding conception. Administered subcutaneously by a healthcare professional, self-injection is strongly discouraged. Guidance on at-home injection technique will be provided by your doctor or nurse. Dosage and frequency are individualized and determined by your physician based on your specific needs and response. Continue treatment as directed. Commonly reported side effects include injection site reactions (erythema, pruritus, inflammation), nausea, and emesis. Rotate injection sites (abdominal area) daily to minimize irritation. Seek immediate medical attention for dizziness, syncope, abdominal pain, or severe vomiting. Prior to commencing treatment, disclose any history of hepatic or renal impairment, or current breastfeeding status. Complete disclosure of all concurrent medications is crucial, as interactions may influence Cetrolix's efficacy or mechanism of action.
Primary Ingredients of Cetrolix 0.25mg Injection
There is no text provided to rephrase.
Uses of Cetrolix 0.25mg Injection
Inability to conceive in women
Major Benefits of Cetrolix 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cetrolix 0.25mg Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetrolix 0.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cetrolix 0.25mg Injection works:
During infertility treatment in women, premature egg release can occur before the eggs are mature enough for fertilization. Cetrolix 0.25mg Injection inhibits a naturally occurring hormone, thus preventing this premature ovarian expulsion of eggs.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Cetrolix 0.25mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Cetrolix 0.25mg Injection during pregnancy carries a substantial risk. Pregnant individuals should consult their physician before use, given that research in both animal and human subjects indicates considerable harm to the fetus.
Breast feedingUNSAFE
Administration of Cetrolix 0.25mg Injection is contraindicated during lactation. Evidence indicates potential infant harm from this medication.
DrivingSAFE
Administering a 0.25mg injection of Cetrolix typically does not impair driving ability.
KidneyCAUTION
Patients with kidney impairment should use Cetrolix 0.25mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Cetrolix 0.25mg Injection is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should receive Cetrolix 0.25mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Cetrolix 0.25mg Injection :
Should you forget a dose of Cetrolix 0.25mg Injection, seek your physician's advice.
Facts to Know About Cetrolix 0.25mg Injection
| Label | Value |
|---|---|
| Chemical Type | Amino acid chains |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
| Actions | GnRH receptor blockers |
3,018 People bought this recently